HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro.

Abstract
The activation of the inflammatory/immunological response system is suggested to be related to the pathophysiology of schizophrenia. Aripiprazole is a novel atypical antipsychotic, which is a high-affinity dopamine D(2) receptor partial agonist. Atypical antipsychotics, all of which have dopamine D(2) receptor antagonism, have recently reported to have significantly inhibitory effects on interferon (IFN)-gamma-induced microglial activation in vitro. In the present study, we investigated whether or not aripiprazole also has anti-inflammatory effect on IFN-gamma-induced microglial activation. Not quinpirole, dopamine D(2) full agonist, but aripiprazole significantly inhibited the generation of nitric oxide (NO) and tumor necrosis factor (TNF)-alpha from IFN-gamma-activated microglia and suppressed the IFN-gamma-induced elevation of intracellular Ca(2+) concentrations ([Ca(2+)](i)) in murine microglial cells. Increased [Ca(2+)](i) has been reported to be required, but by itself not sufficient, for the release of NO and certain cytokines. As a result, we can speculate that aripiprazole may inhibit IFN-gamma-induced microglial activation through the suppression of IFN-gamma-induced elevation of [Ca(2+)](i) in microglia. Our results demonstrated that not only antipsychotics which have dopamine D(2) receptor antagonism but also aripiprazole have anti-inflammatory effects via the inhibition of microglial activation. Antipsychotics may therefore have a potentially useful therapeutic effect on patients with schizophrenia by reducing the microglial inflammatory reactions.
AuthorsTakahiro Kato, Yoshito Mizoguchi, Akira Monji, Hideki Horikawa, Satoshi O Suzuki, Yoshihiro Seki, Toru Iwaki, Sadayuki Hashioka, Shigenobu Kanba
JournalJournal of neurochemistry (J Neurochem) Vol. 106 Issue 2 Pg. 815-25 (Jul 2008) ISSN: 1471-4159 [Electronic] England
PMID18429930 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antipsychotic Agents
  • Dopamine Agonists
  • Piperazines
  • Quinolones
  • Receptors, Dopamine D2
  • Tumor Necrosis Factor-alpha
  • Quinpirole
  • Nitric Oxide
  • Interferon-gamma
  • Aripiprazole
  • Calcium
Topics
  • Analysis of Variance
  • Animals
  • Animals, Newborn
  • Antipsychotic Agents (pharmacology)
  • Aripiprazole
  • Brain (cytology)
  • Calcium (metabolism)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Dopamine Agonists (pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Interferon-gamma (pharmacology)
  • Mice
  • Microglia (drug effects)
  • Neurons
  • Nitric Oxide (metabolism)
  • Piperazines (pharmacology)
  • Quinolones (pharmacology)
  • Quinpirole (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D2 (genetics, metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: